LB Pharmaceuticals Inc Common Stock
LBRX
$49.30+2.26%
Delayed · as of Aug 25, 2026, 1:14 PM ET
Mkt cap
$803.38M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-2.42
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Use this LBRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LBRX income, balance, and cash tables.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company in the Healthcare sector.
Latest cached LB Pharmaceuticals Inc Common Stock (LBRX) net income for FY2025 was -$25.2M. Statements: https://lician.com/financials/lbrx
LB Pharmaceuticals Inc Common Stock (LBRX) market capitalization is $803.4M on the latest cached snapshot.
LB Pharmaceuticals Inc Common Stock (LBRX) cached previous close $48.21; day range $48.50 – $50.16; volume 106,700. Session quote: https://lician.com/quote/lbrx
LB Pharmaceuticals Inc Common Stock (LBRX) latest cached earnings event is "LBRX earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached LBRX filing is 8-K · Sep 15, 2026. Filings: https://lician.com/sec/lbrx